ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,749.00
0.35%
S&P ASX All Technology
3,067.50
0.14%
Brent Oil
82.825
-1.34%
US Dollar vs AUD
1.51319
0.16%
Bitcoin
60,911.15
-3.39%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Kodiak Sciences Inc (KOD)

  7. Kodiak Sciences Inc (KOD) News

KOD

Kodiak Sciences (KOD)

Kodiak Sciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:KOD
DateTimeSourceHeadlineSymbolCompany
03/05/202406:30PR Newswire (US)Kodiak Sciences Data at ARVO 2024 Highlight Depth of Early and Late-Phase Retina Pipeline including Advancements with High Drug-Antibody-Ratio Therapeutics Built on Kodiak's Antibody Biopolymer Conjugate (ABC) PlatformNASDAQ:KODKodiak Sciences Inc
28/03/202421:30PR Newswire (US)Kodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:KODKodiak Sciences Inc
26/03/202421:15PR Newswire (US)Kodiak Sciences to Report Fourth Quarter and Full-Year 2023 Financial Results and Host Business Updates Webcast on March 28, 2024NASDAQ:KODKodiak Sciences Inc
15/02/202408:23Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:KODKodiak Sciences Inc
30/01/202422:30PR Newswire (US)Kodiak Sciences Announces Upcoming Presentation of First Time Results of KSI-501ABC Phase 1 Study at the Angiogenesis, Exudation, and Degeneration 2024 Virtual MeetingNASDAQ:KODKodiak Sciences Inc
05/01/202408:15PR Newswire (US)Kodiak Sciences to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:KODKodiak Sciences Inc
22/11/202308:15PR Newswire (US)Kodiak Sciences to Present at the 6th Annual Evercore ISI HealthCONx ConferenceNASDAQ:KODKodiak Sciences Inc
15/11/202308:01PR Newswire (US)Kodiak Sciences Announces Third Quarter 2023 Financial Results and Recent Business HighlightsNASDAQ:KODKodiak Sciences Inc
06/11/202322:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KODKodiak Sciences Inc
06/11/202321:00PR Newswire (US)Kodiak reboots tarcocimab tedromer development program following strong positive results in Phase 3 diabetic retinopathy GLOW study and following dialogue with US regulatory authorities on a regulatory pathway for BLA submissionNASDAQ:KODKodiak Sciences Inc
02/11/202314:21PR Newswire (US)KODIAK SCIENCES ANNOUNCES FIRST TIME PRESENTATION OF PRIMARY ENDPOINT DATA FROM TARCOCIMAB TEDROMER PHASE 3 GLOW STUDY IN PATIENTS WITH DIABETIC RETINOPATHY AT AMERICAN ACADEMY OF OPHTHALMOLOGY ANNUAL MEETINGNASDAQ:KODKodiak Sciences Inc
11/10/202321:00PR Newswire (US)Kodiak Sciences Announces Upcoming Presentations at the 56th Annual Scientific Meeting of the Retina SocietyNASDAQ:KODKodiak Sciences Inc
08/09/202320:00PR Newswire (US)Kodiak Sciences to Present at the Morgan Stanley 21st Annual Global Healthcare ConferenceNASDAQ:KODKodiak Sciences Inc
07/09/202320:00PR Newswire (US)New one-year results for Kodiak's tarcocimab tedromer in the pivotal BEACON trial reinforce durability signal and demonstrate matched efficacy and comparable safety and tolerability in retinal vein occlusionNASDAQ:KODKodiak Sciences Inc
18/08/202307:26Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KODKodiak Sciences Inc
15/08/202306:33Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:KODKodiak Sciences Inc
15/08/202306:12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KODKodiak Sciences Inc
15/08/202306:01PR Newswire (US)Kodiak Sciences Announces Second Quarter 2023 Financial Results and Recent Business HighlightsNASDAQ:KODKodiak Sciences Inc
24/07/202320:45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KODKodiak Sciences Inc
24/07/202320:00PR Newswire (US)Kodiak Sciences Announces Topline Results from its Phase 3 Studies of Tarcocimab Tedromer in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema and Provides Update on Tarcocimab Development ProgramNASDAQ:KODKodiak Sciences Inc
04/07/202306:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KODKodiak Sciences Inc
04/07/202306:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KODKodiak Sciences Inc
28/06/202307:36Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KODKodiak Sciences Inc
28/06/202307:33Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KODKodiak Sciences Inc
28/06/202307:32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KODKodiak Sciences Inc
14/06/202307:34Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KODKodiak Sciences Inc
14/06/202307:31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KODKodiak Sciences Inc
08/06/202306:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KODKodiak Sciences Inc
05/06/202320:07Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:KODKodiak Sciences Inc
31/05/202306:15PR Newswire (US)Kodiak Sciences to Present at Upcoming Investor ConferencesNASDAQ:KODKodiak Sciences Inc
 Showing the most relevant articles for your search:NASDAQ:KOD

Your Recent History

ASX
XMM
S&P ASX 300 Metals and M...
ASX
MQG
Macquarie
FX
AUDCAD
AUD vs CAD
NASDAQ
QQQ
Invesco QQQ Trust Series 1
FX
AUDJPY
AUD vs Yen
ASX
WBC
Westpac Banking
ASX
XFL
S&P ASX 50
NASDAQ
NVDA
NVIDIA
ASX
ANZ
Australia And New Zealan...
NASDAQ
MSFT
Microsoft
NYSE
JPM
JP Morgan Chase
ASX
TLS
Telstra
ASX
QBE
QBE Insurance
FX
GBPAUD
Sterling vs AUD
ASX
XJO
S&P ASX 200
ASX
WDC
Westfield
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved